The post Warsaw Stock Exchange lists its first Bitcoin ETF appeared on BitcoinEthereumNews.com. The Warsaw Stock Exchange has listed its first Bitcoin ETF, offering investors regulated exposure to BTC through futures contracts. Summary The Bitcoin BETA ETF tracks BTC through CME futures and includes a hedging strategy to reduce USD/PLN currency risk. Approved by Poland’s Financial Supervision Authority, the fund is managed by AgioFunds TFI. Bitcoin ETF arrives on Warsaw Stock Exchange The Warsaw Stock Exchange (GPW) has listed its first-ever crypto ETF, the Bitcoin BETA ETF. According to GPW’s official announcement, the Bitcoin BETA ETF does not invest in physical Bitcoin (BTC), but gains exposure through futures contracts traded on the Chicago Mercantile Exchange. To minimize foreign exchange volatility, the fund employs a hedging strategy using forward contracts, insulating investors from fluctuations in the USD/PLN exchange rate. Developed by AgioFunds TFI, the ETF was approved by Poland’s Financial Supervision Authority in June and is backed by Dom Maklerski Banku Ochrony Środowiska S.A. as its market maker. “Offering exposure to Bitcoin through an ETF listed on GPW increases safety of trading, as investors can participate in the cryptocurrency market using an instrument which is supervised, cleared, and subject to the transparency standards applicable to a regulated capital market,” said Michał Kobza, Member of the Management Board of the Warsaw Stock Exchange. The current crypto ETF landscape Globally, Bitcoin ETFs have already gained traction on major exchanges, including Nasdaq, NYSE, and Cboe in the U.S., where a wave of spot Bitcoin ETFs was approved in early 2024. Other prominent markets include the Toronto Stock Exchange in Canada, Germany’s Xetra, Switzerland’s SIX Exchange, Brazil’s B3, and Cboe Australia. These ETFs offer various structures, from physically-backed spot products to futures-based funds, like the one just listed on GPW. Beyond Bitcoin and Ethereum, altcoin ETFs are increasingly gaining traction. According to the latest count by Bloomberg analysts,… The post Warsaw Stock Exchange lists its first Bitcoin ETF appeared on BitcoinEthereumNews.com. The Warsaw Stock Exchange has listed its first Bitcoin ETF, offering investors regulated exposure to BTC through futures contracts. Summary The Bitcoin BETA ETF tracks BTC through CME futures and includes a hedging strategy to reduce USD/PLN currency risk. Approved by Poland’s Financial Supervision Authority, the fund is managed by AgioFunds TFI. Bitcoin ETF arrives on Warsaw Stock Exchange The Warsaw Stock Exchange (GPW) has listed its first-ever crypto ETF, the Bitcoin BETA ETF. According to GPW’s official announcement, the Bitcoin BETA ETF does not invest in physical Bitcoin (BTC), but gains exposure through futures contracts traded on the Chicago Mercantile Exchange. To minimize foreign exchange volatility, the fund employs a hedging strategy using forward contracts, insulating investors from fluctuations in the USD/PLN exchange rate. Developed by AgioFunds TFI, the ETF was approved by Poland’s Financial Supervision Authority in June and is backed by Dom Maklerski Banku Ochrony Środowiska S.A. as its market maker. “Offering exposure to Bitcoin through an ETF listed on GPW increases safety of trading, as investors can participate in the cryptocurrency market using an instrument which is supervised, cleared, and subject to the transparency standards applicable to a regulated capital market,” said Michał Kobza, Member of the Management Board of the Warsaw Stock Exchange. The current crypto ETF landscape Globally, Bitcoin ETFs have already gained traction on major exchanges, including Nasdaq, NYSE, and Cboe in the U.S., where a wave of spot Bitcoin ETFs was approved in early 2024. Other prominent markets include the Toronto Stock Exchange in Canada, Germany’s Xetra, Switzerland’s SIX Exchange, Brazil’s B3, and Cboe Australia. These ETFs offer various structures, from physically-backed spot products to futures-based funds, like the one just listed on GPW. Beyond Bitcoin and Ethereum, altcoin ETFs are increasingly gaining traction. According to the latest count by Bloomberg analysts,…

Warsaw Stock Exchange lists its first Bitcoin ETF

The Warsaw Stock Exchange has listed its first Bitcoin ETF, offering investors regulated exposure to BTC through futures contracts.

Summary

  • The Bitcoin BETA ETF tracks BTC through CME futures and includes a hedging strategy to reduce USD/PLN currency risk.
  • Approved by Poland’s Financial Supervision Authority, the fund is managed by AgioFunds TFI.

Bitcoin ETF arrives on Warsaw Stock Exchange

The Warsaw Stock Exchange (GPW) has listed its first-ever crypto ETF, the Bitcoin BETA ETF. According to GPW’s official announcement, the Bitcoin BETA ETF does not invest in physical Bitcoin (BTC), but gains exposure through futures contracts traded on the Chicago Mercantile Exchange. To minimize foreign exchange volatility, the fund employs a hedging strategy using forward contracts, insulating investors from fluctuations in the USD/PLN exchange rate.

Developed by AgioFunds TFI, the ETF was approved by Poland’s Financial Supervision Authority in June and is backed by Dom Maklerski Banku Ochrony Środowiska S.A. as its market maker.

“Offering exposure to Bitcoin through an ETF listed on GPW increases safety of trading, as investors can participate in the cryptocurrency market using an instrument which is supervised, cleared, and subject to the transparency standards applicable to a regulated capital market,” said Michał Kobza, Member of the Management Board of the Warsaw Stock Exchange.

The current crypto ETF landscape

Globally, Bitcoin ETFs have already gained traction on major exchanges, including Nasdaq, NYSE, and Cboe in the U.S., where a wave of spot Bitcoin ETFs was approved in early 2024. Other prominent markets include the Toronto Stock Exchange in Canada, Germany’s Xetra, Switzerland’s SIX Exchange, Brazil’s B3, and Cboe Australia. These ETFs offer various structures, from physically-backed spot products to futures-based funds, like the one just listed on GPW.

Beyond Bitcoin and Ethereum, altcoin ETFs are increasingly gaining traction. According to the latest count by Bloomberg analysts, there are now over 90 crypto-related ETF and ETP filings, with a growing portion focused on altcoins.

The momentum is expected to accelerate further following the SEC’s recent approval of generic listing standards for commodity-based trust shares in the U.S. This regulatory change streamlines the approval process for spot crypto ETFs, allowing exchanges to list qualifying products without requiring full-length reviews for each one. Bloomberg ETF analyst Eric Balchunas highlighted the potential impact of this change, stating, “the last time they implemented a generic listing standard for ETFs, launches tripled. Good chance we see north of 100 crypto ETFs launched in the next 12 months.”

Source: https://crypto.news/warsaw-stock-exchange-lists-its-first-bitcoin-etf/

Market Opportunity
Union Logo
Union Price(U)
$0.002464
$0.002464$0.002464
-0.16%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26